Investors who lost money on GSK plc(GSK) should contact Levi & Korsinsky about pending Class Action - GSK
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
RFK Jr. tells HHS staffers childhood vaccines, psychiatric drugs on his radar
In his first address to staffers at HHS since becoming secretary of the department on Feb. 13, Robert F. Kennedy Jr. Tuesday ...
FDA Approves More Broadly Protective Meningococcal Vaccine
TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive ...
GlaxoSmithKline share price extends post-Q3 results rally. Jumps 36% in two days
GlaxoSmithKline share price has surged more than 36% in two sessions after the announcement of Q3 results. The stock has ...
MyJoyOnline11h
Africa-specific research key to tackling continent’s health challenges, says GSK’s Dr. Juliet Addo
Dr. Juliet Addo, Academic Engagement Director for Ghana and Head of the Africa Open Lab at GSK, has reaffirmed the importance ...
GSK rises Tuesday, outperforms market
GSK PLC closed 20.87% below its 52-week high of £18.24, which the company reached on May 16th.
BioPharma Dive14h
GSK’s 5-in-1 meningococcal shot wins FDA approval
Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...
STAT15h
Pharmalittle: We’re reading about the impact of HHS firings, a GSK vaccine approval, and more
Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week
GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...
Valeo Financial Advisors LLC Sells 3,907 Shares of GSK plc (NYSE:GSK)
Valeo Financial Advisors LLC lowered its position in GSK plc (NYSE:GSK – Free Report) by 31.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and ...
GSK's Strong Performance: Why I'm Upgrading To 'Strong Buy'
GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...
Business Wire1d
GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...